2020 – Page 30 – REGENHEALTHSOLUTIONS (RHS)

PIER MARIA FORNASARI
2020-04-29

Santhera and Cold Spring Harbor Laboratory to Investigate Lonodelestat in COVID-19-related Acute Respiratory Distress Syndrome (ARDS)

Santhera Pharmaceuticals (SIX: SANN) has entered into a collaboration agreement with Cold Spring Harbor Laboratory (CSHL) to investigate the potential of lonodelestat (POL6014), a potent inhibitor of human neutrophil elastase (hNE), as a therapeutic intervention for COVID-19-related acute respiratory distress syndrome (ARDS). Researchers at CSHL are part of a recently formed consortium of international non-clinical and

No Comments InCovid-19

PIER MARIA FORNASARI
2020-04-29

Covid-19: concerns grow over inflammatory syndrome emerging in children

Doctors in the UK have been warned over a rising number of children presenting with a multisystem inflammatory state and needing intensive care. In an urgent alert shared by North Central London Clinical Commissioning Group and the Paediatric Intensive Care Society, doctors were told that while the unspecified number of cases may be connected to the

No Comments InCovid-19

PIER MARIA FORNASARI
2020-04-27

New research finds a connection between NETs and a more severe disease course of Covid-19

New research finds a connection between destructive white blood cells and a more severe disease course in patients with COVID-19. Source University of Michigan “We found that patients with COVID-19 infection have higher blood levels of neutrophil extracellular traps, also called NETs, which are a product of an inflammatory type of neutrophil cell death called NETosis,” says first

No Comments InCovid-19

PIER MARIA FORNASARI
2020-04-26

Fighting the Covid-19 ‘infodemic’: conspiration theories and fake news

Disinformation and conspiracy theories surrounding the global coronavirus pandemic have flooded the internet – often with an additional nudge from world leaders and celebrities – presenting a challenge for health authorities, social media platforms, journalists, fact-checkers and concerned citizens worldwide. US health officials scrambled this week to put out a fire started by President Donald Trump when he suggested in his Thursday press briefing that injecting disinfectant

No Comments InCovid-19

PIER MARIA FORNASARI
2020-04-26

FDA OKs ADHD Video Game Therapy for Emergency Release During the Pandemic

In response to U.S. stay-at-home orders, the FDA has cleared the way for the emergency release of several validated digital therapeutics including Endeavor™ (AKL-TO1), a digital attention treatment from Akili Interactive. Endeavor™, a computer game experience that aims to improve attention function in children ages 8-12 with primarily inattentive or combined-type ADHD, is now available

No Comments InCovid-19

PIER MARIA FORNASARI
2020-04-25

Higher Levels of NETs in Blood Associated with More Severe COVID-19

New study explores the connection between levels of a type of white blood cell, known as a neutrophil, with the severity of COVID-19. New research finds a connection between destructive white blood cells and a more severe disease course in patients with COVID-19. “We found that patients with COVID-19 infection have higher blood levels of

No Comments InCovid-19

PIER MARIA FORNASARI
2020-04-25

For WHO “No evidence” that recovered COVID-19 patients cannot be reinfected, warning governments against issuing “immunity passports”

The World Health Organization (WHO) said that there was currently “no evidence” that people who have recovered from COVID-19 and have antibodies are protected from a second coronavirus infection. In a scientific brief, the United Nations agency warned governments against issuing “immunity passports” or “risk-free certificates” to people who have been infected as their accuracy

No Comments InCovid-19

PIER MARIA FORNASARI
2020-04-25

A real-time dashboard of clinical trials for COVID-19

In response to the global coronavirus disease 2019 (COVID-19) emergency, clinical trial research assessing the efficacy and safety of clinical candidate interventions to treat COVID-19 are emerging at an unprecedented rate. As of April 21, 2020, well over 500 clinical trials have been registered at the various international and national clinical trial registry sites. Most

No Comments InCLINICAL TRIALS Covid-19

PIER MARIA FORNASARI
2020-04-23

Nose cells identified as likely Covid-19 entry points

Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to get into our cells. The identification of these cells by researchers from the Wellcome

No Comments InCovid-19

PIER MARIA FORNASARI
2020-04-23

New study looks at connection between sense of smell and COVID-19

Research reports and anecdotes show that people with COVID -19 can experience a reduced sense of smell and taste. Researchers at Stockholm University will join a large international team investigating the connection. Do you think you have the new corona virus? If you know you do or suspect it, you can participate in a new study.

No Comments InCovid-19

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

Archives: 2020-04-29

Santhera and Cold Spring Harbor Laboratory to Investigate Lonodelestat in COVID-19-related Acute Respiratory Distress Syndrome (ARDS)

Covid-19: concerns grow over inflammatory syndrome emerging in children

New research finds a connection between NETs and a more severe disease course of Covid-19

Fighting the Covid-19 ‘infodemic’: conspiration theories and fake news

FDA OKs ADHD Video Game Therapy for Emergency Release During the Pandemic

Higher Levels of NETs in Blood Associated with More Severe COVID-19

For WHO “No evidence” that recovered COVID-19 patients cannot be reinfected, warning governments against issuing “immunity passports”

A real-time dashboard of clinical trials for COVID-19

Nose cells identified as likely Covid-19 entry points

New study looks at connection between sense of smell and COVID-19